Medicure (OTCMKTS:MCUJF) Posts Earnings Results, Beats Estimates By $999.04 EPS
by Sarita Garza · The Markets DailyMedicure (OTCMKTS:MCUJF – Get Free Report) released its quarterly earnings results on Thursday. The company reported $999.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $999.04, Zacks reports. Medicure had a negative return on equity of 17.91% and a negative net margin of 13.10%.
Medicure Price Performance
MCUJF remained flat at $0.96 during trading on Thursday. Medicure has a one year low of $0.60 and a one year high of $0.97. The business has a fifty day moving average price of $0.84 and a two-hundred day moving average price of $0.84. The stock has a market cap of $10.06 million, a P/E ratio of -4.01 and a beta of 1.11. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.44 and a quick ratio of 1.00.
About Medicure
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.